Early-Stage Engineering: The Key to Business Profitability
Bringing biotechnological production from the laboratory to an industrial scale is an extremely challenging task, requiring in-depth experience and comprehensive expertise to develop a profitable business case. ZETA experts know what is important and offer their support through all phases of a CAPEX project. One of their most fundamental insights is to take the right path during the initial phases of engineering to ensure success.
ZETA pilot bioreactor for process development and optimization
Bioreactor scale-up example, monitoring oxygen transfer
The ZETA Group is an end-to-end solution provider operating globally and specializing in the design, construction, automation, digitalization and qualification of customer-specific biopharmaceutical systems for aseptic process solutions.
As general planners (EPCM), ZETA manages major, high-complexity pharma projects and specifically reduces interfaces—from the planning and construction of the process system through the cleanroom design up to the technical building infrastructure. This design-build approach accelerates the project execution time by up to 50% and leads to creation of value earlier in the customer’s capex projects. In doing so, ZETA provides an active contribution to the rapid market introduction of vital active ingredients and patients benefit from earlier availability of pharmaceuticals such as anti-cancer medications, insulin and vaccines.
